Amcell Corp., Amgen deal

The Miltenyi technology uses an antibody bound to an iron dextran complex, which in turn binds to an antigen on target cells. The mixture is run through a column containing paramagnetic elements. When a coil around the column is turned on, creating a magnetic field, the paramagnetic elements become magnetized and attract the iron dextran complex bound to target cells. ...